Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Emma L McClure"'
Publikováno v:
Digestive Diseases and Sciences. 68:223-232
Publikováno v:
Inflammatory Bowel Diseases. 28:1787-1789
Lay Summary In this case series, 6 patients with chronic pouchitis (n = 3), cuffitis (n = 2), or Crohn’s-like disease of the pouch (n = 1) were treated with tofacitinib. One patient achieved clinical response; however, all patients ultimately disco
Autor:
Benjamin H. Mullish, Laura Martinez‐Gili, Elena Chekmeneva, Gonçalo D. S. Correia, Matthew R. Lewis, Verena Horneffer‐Van Der Sluis, Lauren A. Roberts, Julie A. K. McDonald, Alexandros Pechlivanis, Julian R. F. Walters, Emma L. McClure, Julian R. Marchesi, Jessica R. Allegretti
Background: Factors influencing recurrence risk in primary Clostridioides difficile infection (CDI) are poorly understood, and tools predicting recurrence are lacking. Perturbations in bile acids (BAs) contribute to CDI pathogenesis and may be releva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::933f0d210898b0c1142be93d362fb0e3
http://hdl.handle.net/10044/1/100250
http://hdl.handle.net/10044/1/100250
Autor:
Benjamin H. Mullish, Laura Martinez-Gili, Elena Chekmeneva, Gonçalo D. S. Correia, Matthew R. Lewis, Verena Horneffer-Van Der Sluis, Julie A. K. McDonald, Alexandros Pechlivanis, Julian R. F. Walters, Emma L McClure, Julian R. Marchesi, Jessica R. Allegretti
1.AbstractBackgroundFactors that influence recurrence risk in primary Clostridioides difficile infection (CDI) are poorly understood, and tools to predict recurrence are lacking. Perturbations in microbial-derived bile acids (BAs) contribute to CDI p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6e39b8169af413b1e7721255325684d
http://hdl.handle.net/10044/1/104368
http://hdl.handle.net/10044/1/104368
Autor:
Travis E. Gibson, Lynn Bry, Georg K. Gerber, Jennifer J Dawkins, Jessica R. Allegretti, Mary L. Delaney, Emma L. McClure
Publikováno v:
Microbiome. 10
Background Clostridioides difficile infection (CDI) is the most common hospital acquired infection in the USA, with recurrence rates > 15%. Although primary CDI has been extensively linked to gut microbial dysbiosis, less is known about the factors t
Autor:
Ahmad Najdat Bazarbashi, Lin Shen, Danny Wong, Emma L. McClure, Walter W. Chan, Jessica R. Allegretti, Kunal Jajoo, Thomas R. McCarty, Kelly Hathorn, Joyce C. Zhou, Cheikh Nije, Walker D. Redd
Publikováno v:
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open, Vol 5, Iss 5, Pp 622-625 (2021)
JGH Open, Vol 5, Iss 5, Pp 622-625 (2021)
Publikováno v:
Digestive diseases and sciences.
The comparative long-term survival of first-line biologics for UC and reasons for drug discontinuation are poorly understood. We sought to compare the long-term drug survival related to non-response (NR) and adverse effects (AEs) for vedolizumab, ada
Autor:
Jessica R. Allegretti, Emma L. McClure, Matthew J. Hamilton, Andrew Canakis, Beth-Ann Norton, Jenna Marcus, Punyanganie S. de Silva, Sonia Friedman, Joshua R. Korzenik, Rachel W. Winter
Publikováno v:
Inflammatory Bowel Diseases. 27:2031-2033
Publikováno v:
American Journal of Gastroenterology. 116:S334-S335
Publikováno v:
Gastroenterology. 162:S-604